Negara: Inggris
Bahasa: Inggris
Sumber: MHRA (Medicines & Healthcare Products Regulatory Agency)
Erythromycin lactobionate
Advanz Pharma
J01FA01
Erythromycin lactobionate
1gram
Powder for solution for infusion
Intravenous
No Controlled Drug Status
Valid as a prescribable product
BNF: 05010500; GTIN: 5060064171196
OBJECT 1 ERYTHROMYCIN LACTOBIONATE 1G POWDER FOR SOLUTION FOR INFUSION Summary of Product Characteristics Updated 11-Jan-2018 | Concordia International - formerly AMCo 1. Name of the medicinal product Erythrocin I.V. Lactobionate 1g Powder for Solution for Infusion Erythromycin Lactobionate 1g Powder for Solution for Infusion 2. Qualitative and quantitative composition Active: Erythromycin as Erythromycin lactobionate 1 g / vial 3. Pharmaceutical form Powder for solution for infusion 4. Clinical particulars 4.1 Therapeutic indications This medicine is indicated in severe and immunocompromised cases of infections caused by sensitive organisms where high blood levels are required at the earliest opportunity or when the oral route is compromised. 1. Upper Respiratory Tract infections: tonsillitis, peritonsillar abscess, pharyngitis, laryngitis, sinusitis, secondary infections in influenza and common colds 2. Lower Respiratory Tract infections: tracheitis, acute and chronic bronchitis, pneumonia (lobar pneumonia, bronchopneumonia, primary atypical pneumonia), bronchiectasis, Legionnaire's disease 3. Ear infection: otitis media and otitis externa, mastoiditis 4. Oral infections: gingivitis, Vincent's angina 5. Eye infections: blepharitis 6. Skin and soft tissue infections: boils and carbuncles, paronychia, abscesses, pustular acne, impetigo, cellulitis, erysipelas 7. Gastrointestinal infections: cholecystitis, staphylococcal enterocolitis 8. Prophylaxis: peri-operative secondary infection prophylaxis, severe trauma and burns secondary infection prophylaxis, endocarditis prophylaxis (dental procedures) 9. Septicaemia 10. Endocarditis 11. Other infections: osteomyelitis, urethritis, gonorrhoea, syphilis, lymphogranuloma venereum, diphtheria, prostatitis, scarlet fever. 4.2 Posology and method of administration Adults: severe and immunocompromised infections, 50mg/kg/day, preferably by continuous infusion (equivalent to 4g per day for adults). Mild to moderate infections (oral route compromised) 25mg/kg/day. Newborn infa Baca dokumen lengkapnya